Blog

For life science organizations, scientific, medical, and patient advocacy conferences are much more than dates on a calendar. They are opportunities to share data, engage with key opinion leaders (KOLs),...

In many pharmaceutical and biotechnology companies, publications and medical communications teams are no longer viewed as executional functions responsible solely for delivering manuscripts, congress presentations, and publication plans. They’re increasingly expected to be strategic partners. That...

One of the most common misconceptions in regulatory writing is that quality control (QC) happens after a document is complete. In reality, waiting until the final review to identify issues...

The medical information contact center is the epicenter for service in many pharmaceutical and biotech companies, as it is the hub for inquiries, concerns, and feedback that come directly from...

Mary Ellis Bogden joined Med Communications earlier this year as Associate Director, Regulatory Writing Services. When it comes to navigating complex regulatory pathways and bringing therapies closer to patients, few...